Neogen share price today

(NEOG)

Neogen share price is $13.17 & ₹1,116.59 as on 11 Dec 2024, 2.30 'hrs' IST

$13.17

▲

0.06

(0.46%)

Market is closed - opens 8 PM, 11 Dec 2024

View live Neogen share price in Dollar and Rupees. Guide to invest in Neogen from India. Also see the sentimental analysis on Indian investors investing in Neogen. Get details on the Indian mutual funds that are investing in Neogen. Get Analyst recommendations and forecasts along with all the Neogen's financials.

Neogen share price movements

$12.53
$13.35
$13.17
4.86%
Downside
Day's Volatility :6.11%
Upside
1.31%
$11.46
$20.89
$13.17
12.98%
Downside
52 Weeks Volatility :45.14%
Upside
36.96%

Neogen Returns

Period	Neogen Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.89%	-6.6%	0.0%
6 Months	-27.28%	-0.9%	0.0%
1 Year	-30.62%	9.1%	0.0%
3 Years	-69.17%	7.8%	-20.0%

Neogen Key Statistics

in dollars & INR

Previous Close	$13.11
Open	$13.09
Today's High	$13.345
Today's Low	$12.53
Market Capitalization	$2.9B
Today's Volume	$2.1M
52 Week High	$20.89
52 Week Low	$11.46
Revenue TTM	$912.2M
EBITDA	$179.5M
Earnings Per Share (EPS)	$-0.11
Profit Margin	-2.58%
Quarterly Earnings Growth YOY	-0.86%
Return On Equity TTM	-0.75%

How to invest in Neogen from India?

It is very easy for Indian residents to invest directly in Neogen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neogen stock in both rupees (INR) and dollars (USD). Search for Neogen or NEOG on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neogen or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neogen shares which would translate to 0.064 fractional shares of Neogen as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Neogen

-19%

Period: Sep 11, 2024 to Dec 10, 2024. Change in 30 Days versus previous period

Search volume for Neogen on INDmoney from India has reduced in the last 30 days as on Dec 11, 2024. -19% less investors are searching Neogen in the last 30 days versus the previous period.

Global Institutional Holdings in Neogen

BlackRock Inc
11.54%
Vanguard Group Inc
9.10%
NORGES BANK
8.40%
William Blair Investment Management, LLC
6.12%
Select Equity Group LP
6.11%
Baillie Gifford & Co Limited.
5.18%

Analyst Recommendation on Neogen

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Neogen(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Neogen

What analysts predicted

Upside of 25.28%

Current:

$13.17

Target:

$16.50

Insights on Neogen

Price Movement
In the last 7 days, NEOG stock has moved down by -6.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 236.79M → 216.96M (in $), with an average decrease of 8.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -2.02M → -12.60M (in $), with an average decrease of 150.3% per quarter
NEOG vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 6.9% return, outperforming this stock by 37.3%
NEOG vs A (3 yr)
In the last 3 years, Neogen Corp has experienced a drawdown of -69.2%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 57.4%
Price to Sales
ForNEOG every $1 of sales, investors are willing to pay $3.1, whereas for Agilent Technologies Inc., the investors are paying $6.4 for every $1 of sales.

Neogen Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$414.2M	↑ 2.97%
Net Income	$60.2M	↓ 4.7%
Net Profit Margin	14.53%	↓ 1.17%

	FY20	Y/Y Change
Revenue	$418.2M	↑ 0.96%
Net Income	$59.5M	↓ 1.16%
Net Profit Margin	14.22%	↓ 0.31%

	FY21	Y/Y Change
Revenue	$468.5M	↑ 12.03%
Net Income	$60.9M	↑ 2.37%
Net Profit Margin	13.0%	↓ 1.22%

	FY22	Y/Y Change
Revenue	$527.2M	↑ 12.53%
Net Income	$48.3M	↓ 20.65%
Net Profit Margin	9.16%	↓ 3.84%

	FY23	Y/Y Change
Revenue	$822.4M	↑ 56.01%
Net Income	$-22.9M	↓ 147.34%
Net Profit Margin	-2.78%	↓ 11.94%

	FY24	Y/Y Change
Revenue	$924.2M	↑ 12.37%
Net Income	$-9.4M	↓ 58.81%
Net Profit Margin	-1.02%	↑ 1.76%

	Q2 FY23	Q/Q Change
Revenue	$241.8M	↑ 10.79%
Net Income	$5.6M	↓ 31.97%
Net Profit Margin	2.3%	↓ 1.45%

	Q3 FY23	Q/Q Change
Revenue	$229.0M	↓ 5.3%
Net Income	$1.5M	↓ 73.03%
Net Profit Margin	0.66%	↓ 1.64%

	Q4 FY23	Q/Q Change
Revenue	$229.6M	↑ 0.28%
Net Income	$-3.5M	↓ 332.0%
Net Profit Margin	-1.52%	↓ 2.18%

	Q1 FY24	Q/Q Change
Revenue	$228.8M	↓ 0.36%
Net Income	$-2.0M	↓ 42.01%
Net Profit Margin	-0.88%	↑ 0.64%

	Q2 FY24	Q/Q Change
Revenue	$236.8M	↑ 3.49%
Net Income	$-5.4M	↑ 167.8%
Net Profit Margin	-2.29%	↓ 1.41%

	Q3 FY24	Q/Q Change
Revenue	$217.0M	↓ 8.37%
Net Income	$-12.6M	↑ 132.85%
Net Profit Margin	-5.81%	↓ 3.52%

	FY19	Y/Y Change
Total Assets	$695.7M	↑ 12.58%
Total Liabilities	$57.8M	↑ 0.01%

	FY20	Y/Y Change
Total Assets	$797.2M	↑ 14.58%
Total Liabilities	$72.0M	↑ 24.49%

	FY21	Y/Y Change
Total Assets	$920.2M	↑ 15.43%
Total Liabilities	$79.8M	↑ 10.85%

	FY22	Y/Y Change
Total Assets	$992.9M	↑ 7.9%
Total Liabilities	$105.6M	↑ 32.25%

	FY23	Y/Y Change
Total Assets	$4.6B	↑ 358.69%
Total Liabilities	$1.4B	↑ 1245.47%

	FY24	Y/Y Change
Total Assets	$4.5B	↓ 0.12%
Total Liabilities	$1.4B	↓ 1.09%

	Q2 FY23	Q/Q Change
Total Assets	$4.6B	↑ 1.01%
Total Liabilities	$1.4B	↑ 2.68%

	Q3 FY23	Q/Q Change
Total Assets	$4.6B	↑ 0.15%
Total Liabilities	$1.4B	↓ 0.37%

	Q4 FY23	Q/Q Change
Total Assets	$4.6B	↑ 0.91%
Total Liabilities	$1.5B	↑ 2.82%

	Q1 FY24	Q/Q Change
Total Assets	$4.6B	↓ 0.43%
Total Liabilities	$1.4B	↓ 1.27%

	Q2 FY24	Q/Q Change
Total Assets	$4.6B	↑ 0.04%
Total Liabilities	$1.4B	↑ 0.26%

	Q3 FY24	Q/Q Change
Total Assets	$4.5B	↓ 1.77%
Total Liabilities	$1.4B	↓ 5.0%

	FY19	Y/Y Change
Operating Cash Flow	$63.8M	↓ 7.65%
Investing Cash Flow	$-119.1M	↑ 43.41%
Financing Cash Flow	$13.9M	↓ 39.14%

	FY20	Y/Y Change
Operating Cash Flow	$85.9M	↑ 34.52%
Investing Cash Flow	$-88.8M	↓ 25.48%
Financing Cash Flow	$29.4M	↑ 111.56%

	FY21	Y/Y Change
Operating Cash Flow	$81.1M	↓ 5.58%
Investing Cash Flow	$-105.6M	↑ 18.9%
Financing Cash Flow	$33.5M	↑ 14.08%

	FY22	Y/Y Change
Operating Cash Flow	$68.0M	↓ 16.09%
Investing Cash Flow	$-97.2M	↓ 7.9%
Financing Cash Flow	$6.8M	↓ 79.69%

	FY23	Y/Y Change
Operating Cash Flow	$41.0M	↓ 39.7%
Investing Cash Flow	$201.0M	↓ 306.77%
Financing Cash Flow	$-118.1M	↓ 1833.17%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$91.0M	↓ 632.93%
Investing Cash Flow	$6.9M	↑ 0.0%
Financing Cash Flow	$252.0K	↓ 100.63%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$23.0M	↓ 74.71%
Investing Cash Flow	$-8.7M	↓ 226.29%
Financing Cash Flow	$1.1M	↑ 321.43%

Neogen Technicals Summary

Sell

Neutral

Buy

Neogen is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Neogen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Neogen Corp	-24.57%	-27.28%	-30.62%	-69.17%	-63.8%
Idexx Laboratories, Inc.	1.7%	-13.53%	-18.41%	-26.53%	75.85%
Agilent Technologies Inc.	6.03%	6.59%	10.2%	-9.19%	69.55%
Thermo Fisher Scientific, Inc.	-2.02%	-6.92%	7.74%	-17.05%	67.19%
Danaher Corp.	-3.66%	-11.44%	6.64%	-26.43%	57.78%
Iqvia Holdings Inc.	-6.36%	-6.56%	-6.54%	-24.67%	40.28%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Neogen Corp	865.0	NA	0.66	0.46	-0.01	0.01	NA	14.47
Idexx Laboratories, Inc.	41.3	41.3	4.5	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	31.62	31.62	2.38	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.68	32.68	1.99	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	42.91	42.91	3.04	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.66	26.66	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Neogen Corp	Buy	$2.7B	-63.8%	865.0	-2.58%
Idexx Laboratories, Inc.	Buy	$35.0B	75.85%	41.3	22.53%
Agilent Technologies Inc.	Buy	$40.0B	69.55%	31.62	21.75%
Thermo Fisher Scientific, Inc.	Buy	$199.2B	67.19%	32.68	14.48%
Danaher Corp.	Buy	$164.6B	57.78%	42.91	16.39%
Iqvia Holdings Inc.	Buy	$36.9B	40.28%	26.66	9.17%

About Neogen

neogen corporation develops and markets products dedicated to food and animal safety. the company’s food safety division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. neogen’s animal safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.

Organization	Neogen
Employees	2917
CEO	Mr. John Edward Adent
Industry	Health Technology

Management People of Neogen

Name	Title
Mr. John Edward Adent	President, CEO & Director
Mr. David H. Naemura	Chief Financial Officer
Mr. Douglas E. Jones	COO & VP
Ms. Amy M. Rocklin Ph.D.	Chief Legal & Compliance Officer and Corporate Secretary
Mr. John Moylan	VP, Corporate Controller & Chief Accounting Officer
Dr. Robert S. Donofrio Ph.D.	VP & Chief Scientific Officer
Sarah Demey	Administrative Manager
Mr. Bill Waelke	Head of Investor Relations
Ms. Julie A. Mann	VP & Chief Human Resources Officer

Important FAQs about investing in Neogen from India :

What is Neogen share price today?

Neogen (NEOG) share price today is $13.17.

Can Indians buy Neogen shares?

Yes, Indians can invest in the Neogen (NEOG) from India.

With INDmoney, you can buy Neogen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Neogen at zero transaction cost.

How can I buy Neogen shares from India?

It is very easy to buy Neogen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neogen be purchased?

Yes, you can buy fractional shares of Neogen with INDmoney app.

What are the documents required to start investing in Neogen stocks?

To start investing in Neogen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.